Supplementary Figure 3: Characterization of ARLNC1 and its expression. | Nature Genetics

Supplementary Figure 3: Characterization of ARLNC1 and its expression.

From: Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression

Supplementary Figure 3

a) Relative expression of ARLNC1 (FPKM) across 14 prostate cancer cell lines. (b) qPCR analysis of ARLNC1 expression in nine prostate cancer cell lines. Expression levels of several known prostate cancer-associated lncRNAs are also shown. Mean ± s.e.m. are graphed, n = 3. (c) Left: Representative image of ARLNC1 gene structure in AR-positive prostate cancer cells, generated from RACE analysis. Annotations of ARLNC1 in Ensembl and the Encyclopedia of DNA Elements (ENCODE) are also shown. Inset: Expression of ARLNC1 transcripts in MDA-PCa-2b cells, validated by Northern blot. ARLNC1-negative DU145 cells serve as negative control. Primer sequences for Northern blotting probe are listed in Supplementary Table 3. Right: 5’ RACE and 3’ RACE results in MDA-PCa-2b cells and LNCaP cells. Experiments were repeated 3 times with similar results. (d) smFISH images depicting localization of ARLNC1 transcripts in a panel of prostate cancer cell lines. Representative pseudocolored images of MDA-PCa-2b, LNCaP, VCaP, 22Rv1, PC3, RWPE, and DU145 cells probed for ARLNC1 (gray) or GAPDH (gray, control). Nucleus is stained with DAPI (blue). Scale bar, 5 µm; n = 3 independent experiments for each cell line. (e) Scatter plot representing the average number of ARLNC1 transcripts per cell in a panel of prostate cancer cell lines, including MDA-PCa-2b, LNCaP, VCaP, 22Rv1, PC3, RWPE, and DU145. Black line and whiskers depict the mean and s.e.m., respectively (n = 50 cells for each cell line aggregated from 3 independent experiments). (f) Representative gray-scale images of MDA-PCa-2b cells stained for DAPI (nucleus, blue) and ARLNC1, AR or GAPDH transcripts (smFISH, gray). Scale bar, 10 µm. Quantification of the number of molecules per cell and the nucleo-cytoplasmic distribution of each transcript is also represented (n = 60 cells for each sample aggregated from 3 independent experiments). Center line represents mean and error bars represent s.e.m. (g) Percentage of nuclear/cytoplasmic RNA levels of ARLNC1, ACTB, and U1, measured by qRT–PCR after subcellular fractionation of MDA-PCa-2b and LNCaP cells. U1 serves as a positive control for nuclear gene expression, while ACTB RNA serves as a positive control for cytoplasmic gene expression. The graphs show mean ± s.e.m., n = 3 independent experiments for each cell line.

Back to article page